Portfolio Lab

Tandem Diabetes Care Inc

  • Stock
  • Ticker TNDM
  • ISIN US8753722037
  • Nasdaq

Health care · Medical technology · USA

$17.46 +3.93%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Tandem Diabetes Care Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

TNDMGlobal equities (VT)

$10,000 grew to $6,349. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −93.4% in 08/2025, measured from the peak in 12/2021. The old peak has not been reached again yet.

1-year return
−10.5%
5-year return p.a.
−33.9%
10-year return p.a.
−4.4%
Volatility p.a.
83.8%
Largest decline
−93.4%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue283234241249290247255284
Gross profit157118126134167137145160
Operating income-0.6-121-52-238.3-17-14-2.4
EBITDA3.7-117-47-1813-13-9.32.1
Net income0.8-131-52-21-0.6-20-21-7.1
Earnings per share0.01-1.97-0.78-0.31-0.01-0.30-0.31-0.10
Balance sheet
Total assets9689228768758811,1531,1541,159
Liabilities7057677427427261,0211,0241,024
Equity263155133133155132130135
Cash69546492911796373
Long-term debt308309309310310602603603
Cash flow
Operating cash flow11-18-9.58.39.811-35-0.8
Capital expenditure-3.1-3.0-6.2-4.1-6.7-6.3-4.1-4.7
Free cash flow7.6-21-164.23.14.8-39-5.5

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2018 at +1,508.9%, weakest 2017 at −89.0%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026−$0.10
6 Aug 2026−$0.31
7 May 2026−$0.30
19 Feb 2026−$0.01
6 Nov 2025−$0.31
6 Aug 2025−$0.78
30 Apr 2025−$1.97
26 Feb 2025$0.01
6 Nov 2024−$0.35
1 Aug 2024−$0.47
2 May 2024−$0.65
21 Feb 2024−$0.46

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€1.1bn
Market cap in trading currency
$1.22bn
Enterprise value
$1.38bn
P/E
–
P/S
1.13
P/B
9.02
EV/Sales
1.28
EV/EBITDA
–
Earnings yield
–
FCF yield
-3.0%

Results (last four quarters)

Revenue
$1.08bn
Gross profit
$609m
EBITDA
−$7.32m
Net income
−$49.2m
Earnings per share
−$0.72
Revenue per share
$15.41
Revenue growth
+13.8%
Earnings growth
–

Profitability

Gross margin
56.6%
Operating margin
-2.4%
Net margin
-4.6%
Return on equity
-36.7%
Return on assets
-4.2%

Balance sheet and cash flow

Cash
$443m
Cash per share
$6.35
Financial debt
$603m
Debt/equity %
447
Current ratio
3.21
Book value per share
$1.94
Operating cash flow
−$14.6m
Free cash flow
−$36.3m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
69.8m
Volume
2.67m
Avg. volume 3 months
2.23m
Relative volume
1.2

Price and technicals

Price
$17.46
1 day
+3.9%
52-week high
$28.26
52-week low
$12.82
Distance to 52-week high
−38.2%
Distance to 52-week low
+36.2%
Distance to 50-day line
+1.2%
Distance to 200-day line
−7.1%
RSI (14)
48
Volatility 1M
93.9%

Performance

1 week
−13.0%
1 month
+1.8%
3 months
−21.4%
6 months
+16.7%
YTD
−20.6%
1 year
−6.8%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has TNDM performed since 11/2016?

$10,000 grew to $6,349 by 20 Nov 2026, which is −4.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is TNDM?

Volatility was 83.8% per year, measured on monthly returns. The largest decline from a peak was −93.4%, with the low in 08/2025.

How does TNDM compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, TNDM returned −4.4% at 83.8%. The correlation of monthly returns was 0.16; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Tandem Diabetes Care Inc (TNDM): Return and risk